Disease spectrum of intraductal papillary mucinous neoplasm with an associated invasive carcinoma: Invasive ipmn versus pancreatic ductal adenocarcinoma-associated IPMN

Pancreas

Volumn 42, Issue 8, 2013, Pages 1267-1274

  Kang, Mee Joo ^a   Lee, Kyoung Bun ^a   Jang, Jin Young ^a   Kwon, Wooil ^a   Park, Jae Woo ^a   Chang, Ye Rim ^a   Kim, Sun Whe ^a  

^a Seoul National University College of Medicine   (South Korea)

Author keywords

adenocarcinoma; dysplasia; intraductal papillary mucinous neoplasm; pancreas; survival analysis

Indexed keywords

APC PROTEIN; CALVASCULIN; CD24 ANTIGEN; MUCIN 1; PROTEIN MSH2; PROTEIN P16; PROTEIN P53; SMAD4 PROTEIN;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER MORPHOLOGY; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ASSOCIATION; DYSPLASIA; FEMALE; HUMAN; INTRADUCTAL PAPILLARY MUCINOUS TUMOR; INVASIVE CARCINOMA; MAJOR CLINICAL STUDY; MALE; PANCREAS ADENOCARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; UNIVERSITY HOSPITAL;

ADENOCARCINOMA; ADENOCARCINOMA, MUCINOUS; ADENOCARCINOMA, PAPILLARY; AGED; CARCINOMA, PANCREATIC DUCTAL; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; MUCIN-1; MUCIN-2; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; OUTCOME ASSESSMENT (HEALTH CARE); PANCREAS; PANCREATIC NEOPLASMS; PRECANCEROUS CONDITIONS; PROGNOSIS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84887318915     PISSN: 08853177     EISSN: 15364828     Source Type: Journal    
DOI: 10.1097/MPA.0b013e3182954137     Document Type: Article

References (27)

1. Longnecker DS, Adsay NV, Fernandez-del Castillo C, et al. Histopathological diagnosis of pancreatic intraepithelial neoplasia and intraductal papillary-mucinous neoplasms: interobserver agreement. Pancreas. 2005;31:344Y349.
2. Tanaka M, Chari S, Adsay V, et al. International consensus guidelines for management of intraductal papillary mucinous neoplasms and mucinous cystic neoplasms of the pancreas. Pancreatology. 2006;6:17Y32.
3. Wasif N, Bentrem DJ, Farrell JJ, et al. Invasive intraductal papillary mucinous neoplasm versus sporadic pancreatic adenocarcinoma: a stage-matched comparison of outcomes. Cancer. 2010;116:3369Y3377.
4. Yopp AC, Katabi N, Janakos M, et al. Invasive carcinoma arising in intraductal papillary mucinous neoplasms of the pancreas: a matched control study with conventional pancreatic ductal adenocarcinoma. Ann Surg. 2011;253:968Y974.
5. Schmidt CM, White PB, Waters JA, et al. Intraductal papillary mucinous neoplasms: predictors of malignant and invasive pathology. Ann Surg. 2007;246:644Y651; discussion 651-4.
6. Nara S, Onaya H, Hiraoka N, et al. Preoperative evaluation of invasive and noninvasive intraductal papillary-mucinous neoplasms of the pancreas: clinical, radiological, and pathological analysis of 123 cases. Pancreas. 2009;38:8Y16.
7. Salvia R, Fernandez-del Castillo C, Bassi C, et al. Main-duct intraductal papillary mucinous neoplasms of the pancreas. Ann Surg. 2004;239:678Y687.
8. Schnelldorfer T, Sarr MG, Nagorney DM, et al. Experience with 208 resections for intraductal papillary mucinous neoplasm of the pancreas. Arch Surg. 2008;143:639Y646; discussion 646.
9. Hwang DW, Jang JY, Lee SE, et al. Clinicopathologic analysis of surgically proven intraductal papillary mucinous neoplasms of the pancreas in SNUH: a 15-year experience at a single academic institution. Langenbecks Arch Surg. 2012;397:93Y102.
10. Yamaguchi K, Kanemitsu S, Hatori T, et al. Pancreatic ductal adenocarcinoma derived from IPMN and pancreatic ductal adenocarcinoma concomitant with IPMN. Pancreas. 2011;40:571Y580.
11. Adsay NV, Kloppel G, Fukushima N, et al. WHO Classification of Tumours of the Digestive System. Lyon, France: IARC Press
12. Longnecker DS, Adler G, Hruban RH, et al. Pathology and Genetics of Tumours of the Digestive System. Lyon, France: IARC Press; 2000.
13. Furukawa T, Kloppel G, Volkan Adsay N, et al. Classification of types of intraductal papillary-mucinous neoplasm of the pancreas: a consensus study. Virchows Arch. 2005;447:794Y799.
14. Jang JY, Hwang DW, Kim MA, et al. Analysis of prognostic factors and a proposed new classification for invasive papillary mucinous neoplasms. Ann Surg Oncol. 2010;18:644Y650.
15. Poultsides GA, Reddy S, Cameron JL, et al. Histopathologic basis for the favorable survival after resection of intraductal papillary mucinous neoplasmYassociated invasive adenocarcinoma of the pancreas. Ann Surg. 2010;251:470Y476.
16. Maire F, Hammel P, Terris B, et al. Prognosis of malignant intraductal papillary mucinous tumours of the pancreas after surgical resection. Comparison with pancreatic ductal adenocarcinoma. Gut. 2002;51:717Y722.
17. Woo SM, Ryu JK, Lee SH, et al. Survival and prognosis of invasive intraductal papillary mucinous neoplasms of the pancreas: comparison with pancreatic ductal adenocarcinoma. Pancreas. 2008;36:50Y55.
18. Society JP. Classification of Pancreatic Carcinoma. 2nd English ed. Tokyo: Kanehara; 2003.
19. Hruban RH, Takaori K, Klimstra DS, et al. An illustrated consensus on the classification of pancreatic intraepithelial neoplasia and intraductal papillary mucinous neoplasms. Am J Surg Pathol. 2004;28:977Y987.
20. Nara S, Shimada K, Kosuge T, et al. Minimally invasive intraductal papillary-mucinous carcinoma of the pancreas: clinicopathologic study of 104 intraductal papillary-mucinous neoplasms. Am J Surg Pathol. 2008;32:243Y255.
21. Tanaka M, Fernandez-Del Castillo C, Adsay V, et al. International consensus guidelines 2012 for the management of IPMN and MCN of the pancreas. Pancreatology. 2012;12:183Y197.
22. Nakata K, Ohuchida K, Aishima S, et al. Invasive carcinoma derived from intestinal-type intraductal papillary mucinous neoplasm is associated with minimal invasion, colloid carcinoma, and less invasive behavior, leading to a better prognosis. Pancreas. 2011;40:581Y587.
23. Sadakari Y, Ohuchida K, Nakata K, et al. Invasive carcinoma derived from the nonintestinal type intraductal papillary mucinous neoplasm of the pancreas has a poorer prognosis than that derived from the intestinal type. Surgery. 2010;147:812Y817.
24. Adsay NV, Merati K, Basturk O, et al. Pathologically and biologically distinct types of epithelium in intraductal papillary mucinous neoplasms: delineation of an ''intestinal'' pathway of carcinogenesis in the pancreas. Am J Surg Pathol. 2004;28:839Y848.
25. Furukawa T, Hatori T, Fujita I, et al. Prognostic relevance of morphological types of intraductal papillary mucinous neoplasms of the pancreas. Gut. 2011;60:509Y516.
26. Kang MJ, Lee KB, Jang JY, et al. Evaluation of clinical meaning of histological subtypes of intraductal papillary mucinous neoplasm of the pancreas [published ahead of print March 4, 2013. Pancreas. doi: 10.1097/MPA. 0b013e31827cddbc.
27. Hruban RH, Goggins M, Parsons J, et al. Progression model for pancreatic cancer. Clin Cancer Res. 2000;6:2969Y2972.